Economic portfolio
Motilal Oswal Nifty MidSmall Healthcare Index Fund
MOTILAL Motilal Oswal Mutual Fund Nov 2024 — Sep 2026 21 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
21 priced months, Nov 2024 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
58.7% now, 57.8% in Sep 2025 · highest 62.4%, lowest 57.8%
Companies held
30 now, 30 in Sep 2025 · largest single holding 11.8% of equity
How it trades: no clear lean toward recent winners or losers (score -0.00 over 18 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- TATA NIFTY MIDSMALL HEALTHCARE INDEX FUNDTata · 30 shared100.0%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 30 shared48.4%
- Mirae Asset Healthcare FundMirae Asset · 17 shared47.6%
- Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 15 shared44.0%
- Nippon India Nifty Pharma ETFNippon India · 14 shared43.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 14 shared43.1%
- Bandhan BSE Healthcare Index FundBandhan · 30 shared40.8%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 30 shared40.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Piramal Pharma Limited+5.2% +2,453
- 02 Fortis Healthcare Limited+5.3% +2,104
- 03 Krishna Institute of Medical Sciences Limited+8.4% +1,665
- 04 Laurus Labs Limited+5.4% +1,607
- 05 Biocon Limited+2.9% +1,557
- 06 Aurobindo Pharma Limited+5.1% +1,086
- 07 Aster DM Quality Care Limited+5.3% +1,079
- 08 Lupin Limited+5.3% +988
- 09 Granules India Limited+7.0% +778
- 10 Syngene International Limited+5.2% +750
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Laurus Labs Limited | Healthcare | Mid Cap | 11.82% | 6.22 Cr | 31,389 | by Nov 2024 (21 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 7.56% | 3.97 Cr | 19,577 | by Nov 2024 (21 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 7.08% | 3.72 Cr | 22,273 | by Nov 2024 (21 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 6.15% | 3.23 Cr | 41,993 | by Nov 2024 (21 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 5.39% | 2.83 Cr | 12,134 | by Nov 2024 (21 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 4.77% | 2.51 Cr | 4,860 | by Nov 2024 (21 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 4.35% | 2.29 Cr | 9,133 | by Nov 2024 (21 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 4.10% | 2.16 Cr | 11,197 | by Nov 2024 (21 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 3.96% | 2.08 Cr | 56,168 | by Nov 2024 (21 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 3.54% | 1.86 Cr | 6,423 | by Nov 2024 (21 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 3.23% | 1.70 Cr | 11,147 | Apr 2026 (6 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 3.05% | 1.61 Cr | 21,508 | by Nov 2024 (21 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 2.86% | 1.50 Cr | 21,543 | by Nov 2024 (21 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 2.82% | 1.48 Cr | 695 | Mar 2025 (17 mo) |
| Wockhardt Limited | Healthcare | Small Cap | 2.68% | 1.41 Cr | 6,658 | Sep 2025 (11 mo) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 2.61% | 1.37 Cr | 4,182 | Jul 2026 (3 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 2.53% | 1.33 Cr | 3,674 | by Nov 2024 (21 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 2.38% | 1.25 Cr | 6,288 | by Nov 2024 (21 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 2.17% | 1.14 Cr | 420 | by Nov 2024 (21 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.97% | 1.03 Cr | 50,063 | by Nov 2024 (21 mo+) |
| Granules India Limited | Healthcare | Small Cap | 1.91% | 1.01 Cr | 11,886 | by Nov 2024 (21 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 1.90% | 1.00 Cr | 5,568 | by Nov 2024 (21 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 1.85% | 0.98 Cr | 7,143 | by Nov 2024 (21 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 1.84% | 0.97 Cr | 6,344 | Sep 2025 (11 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 1.76% | 0.92 Cr | 3,337 | by Nov 2024 (21 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.42% | 0.75 Cr | 8,696 | Sep 2026 (1 mo) |
| Natco Pharma Limited | Healthcare | Small Cap | 1.14% | 0.60 Cr | 7,241 | by Nov 2024 (21 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 1.11% | 0.58 Cr | 13,112 | by Nov 2024 (21 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 1.06% | 0.56 Cr | 15,303 | by Nov 2024 (21 mo+) |
| Poly Medicure Limited | Healthcare | Small Cap | 0.98% | 0.52 Cr | 3,077 | by Nov 2024 (21 mo+) |
Half of its current holdings have been held for 21 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Anthem Biosciences Limited | Sep 2026 | ▲ New position | +8,696 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +2,453 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +2,104 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +1,665 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +1,607 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +1,557 |
| Pfizer Limited | Sep 2026 | ▼ Complete exit | -1,160 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +1,086 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +1,079 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +988 |
| Granules India Limited | Sep 2026 | ▲ Increasing | +778 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +750 |
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +658 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +609 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +588 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +586 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +564 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +496 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +450 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +381 |
| Natco Pharma Limited | Sep 2026 | ▲ Increasing | +364 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +337 |
| Onesource Specialty Pharma Limited | Sep 2026 | ▲ Increasing | +325 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +324 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +323 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +279 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +212 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +169 |
| Poly Medicure Limited | Sep 2026 | ▲ Increasing | +153 |
| Neuland Laboratories Limited | Sep 2026 | ▲ Increasing | +35 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +21 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +3,709 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +3,234 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +2,710 |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +2,400 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +2,023 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +1,439 |
| Krishna Institute of Medical Sciences Limited | Aug 2026 | ▲ Increasing | +1,347 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +1,263 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +989 |
| Cohance Lifesciences Limited | Aug 2026 | ▲ Increasing | +846 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +783 |
| Granules India Limited | Aug 2026 | ▲ Increasing | +754 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +723 |
| Sai Life Sciences Limited | Aug 2026 | ▲ Increasing | +717 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +560 |
| Natco Pharma Limited | Aug 2026 | ▲ Increasing | +467 |
| Global Health Limited | Aug 2026 | ▲ Increasing | +446 |
| Wockhardt Limited | Aug 2026 | ▲ Increasing | +429 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +414 |
| Onesource Specialty Pharma Limited | Aug 2026 | ▲ Increasing | +408 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▲ Increasing | +405 |
| Narayana Hrudayalaya Ltd. | Aug 2026 | ▲ Increasing | +359 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +304 |
| Acutaas Chemicals Limited | Aug 2026 | ▲ Increasing | +270 |
| Ajanta Pharma Limited | Aug 2026 | ▲ Increasing | +219 |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +215 |
| Poly Medicure Limited | Aug 2026 | ▲ Increasing | +199 |
| Pfizer Limited | Aug 2026 | ▲ Increasing | +79 |
| Neuland Laboratories Limited | Aug 2026 | ▲ Increasing | +45 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +27 |
| Biocon Limited | Jul 2026 | ▲ Increasing | +5,897 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -5,164 |
| Piramal Pharma Limited | Jul 2026 | ▲ Increasing | +5,141 |
| Fortis Healthcare Limited | Jul 2026 | ▲ Increasing | +4,306 |
| Acutaas Chemicals Limited | Jul 2026 | ▲ New position | +3,700 |
| Laurus Labs Limited | Jul 2026 | ▲ Increasing | +3,216 |
| Aurobindo Pharma Limited | Jul 2026 | ▲ Increasing | +2,287 |
| Krishna Institute of Medical Sciences Limited | Jul 2026 | ▲ Increasing | +2,143 |
| Aster DM Quality Care Limited | Jul 2026 | ▲ Increasing | +2,093 |
| Lupin Limited | Jul 2026 | ▲ Increasing | +2,007 |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +1,571 |
| Cohance Lifesciences Limited | Jul 2026 | ▲ Increasing | +1,344 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +1,244 |
| Granules India Limited | Jul 2026 | ▲ Increasing | +1,200 |
| IPCA Laboratories Limited | Jul 2026 | ▲ Increasing | +1,148 |
| Sai Life Sciences Limited | Jul 2026 | ▲ Increasing | +1,141 |
| Mankind Pharma Limited | Jul 2026 | ▲ Increasing | +935 |
| Natco Pharma Limited | Jul 2026 | ▲ Increasing | +743 |
| Global Health Limited | Jul 2026 | ▲ Increasing | +707 |
| Wockhardt Limited | Jul 2026 | ▲ Increasing | +683 |
| Gland Pharma Limited | Jul 2026 | ▲ Increasing | +659 |
| Onesource Specialty Pharma Limited | Jul 2026 | ▲ Increasing | +650 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +644 |
| Narayana Hrudayalaya Ltd. | Jul 2026 | ▲ Increasing | +571 |
| Alkem Laboratories Limited | Jul 2026 | ▲ Increasing | +484 |
| Ajanta Pharma Limited | Jul 2026 | ▲ Increasing | +348 |
| GlaxoSmithKline Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +342 |
| Poly Medicure Limited | Jul 2026 | ▲ Increasing | +316 |
| Pfizer Limited | Jul 2026 | ▲ Increasing | +125 |
| Neuland Laboratories Limited | Jul 2026 | ▲ Increasing | +71 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +43 |
| Biocon Limited | Jun 2026 | ▲ Increasing | +3,840 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +3,495 |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +2,816 |
| Krishna Institute of Medical Sciences Limited | Jun 2026 | ▲ Increasing | +2,112 |
| Laurus Labs Limited | Jun 2026 | ▲ Increasing | +2,102 |
| Onesource Specialty Pharma Limited | Jun 2026 | ▲ Increasing | +1,782 |
| Aster DM Quality Care Limited | Jun 2026 | ▲ Increasing | +1,372 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +1,341 |
Changes compare consecutive month-end disclosures for this portfolio only.